DDOG Form 144 Filed — Kerry Acocella Proposes Sale of 3,958 Shares
Rhea-AI Filing Summary
Form 144 notice for Datadog, Inc. (DDOG) shows a proposed sale of 3,958 Class A Common shares to be executed through Morgan Stanley Smith Barney on NASDAQ with an aggregate market value of $521,585.24. The shares were acquired as RSU/PSU on 09/01/2025 and payment/settlement is recorded on 09/01/2025. The filing lists total shares outstanding of 323,270,704. Recent insider sales by the same person, Kerry Acocella, include 5,142 shares sold on 09/02/2025 for $688,243.85 and a 10b5-1 plan sale of 12,971 shares on 08/29/2025 for $1,815,421.16. The filer certifies no undisclosed material adverse information and references reliance on Rule 10b5-1 where applicable.
Positive
- Disclosure compliance: Form 144 filed and broker/exchange identified, fulfilling regulatory notice requirements
- Use of 10b5-1: Prior sales reference a 10b5-1 plan, indicating pre-established trading instructions that support good governance
Negative
- Insider sales occurred: Recent sales total 18,113 shares over a short period, which could be perceived negatively by some investors
- Plan adoption date not shown: The filing text does not display the date of 10b5-1 plan adoption or instruction, limiting assessment of timing
Insights
TL;DR: Routine insider sales under 10b5-1 and RSU vesting; transaction sizes appear modest relative to outstanding shares.
The filing documents a proposed sale of 3,958 shares and discloses recent sales totaling 18,113 shares by the same individual over the past week. The broker and exchange are identified and the filing states the shares were acquired via RSU/PSU on 09/01/2025. For investors, these are disclosed insider transactions consistent with compensation vesting and an established trading plan (10b5-1), which typically reduces informational asymmetry. The amounts disclosed do not indicate a controlling divestiture given the issuer's 323.27 million shares outstanding.
TL;DR: Disclosure complies with Rule 144 and references 10b5-1; confirms insider attestation of no undisclosed material information.
The notice includes the required attestations and indicates possible reliance on a written 10b5-1 trading plan or instruction dates for prior sales. That procedural compliance is important for governance and insider trading risk management. The filing does not provide dates for plan adoption in the visible text, so reviewers must confirm plan timing elsewhere if evaluating affirmative defenses under insider trading rules.